No Data
No Data
Ardelyx: Kelliher Served as Group Vice Pres, M&A and Business Development, at Horizon Therapeutics >ARDX
Ardelyx: Kelliher Served as Group Vice Pres, M&A and Business Development, at Horizon Therapeutics >ARDX
Ardelyx Appoints Mike Kelliher, as Executive Vice Pres, Corporate Development and Strategy
Ardelyx Appoints Mike Kelliher, as Executive Vice Pres, Corporate Development and Strategy
Ardelyx(ARDX.US) Officer Sells US$664.98K in Common Stocks
$Ardelyx(ARDX.US)$ Officer GRAMMER ELIZABETH A sold 86,000 shares of Common Stocks on Mar 20, 2024 at an average price of $7.7323 for a total value of $664.98K.Source: Announcement What is statement o
Ardelyx Insider Sold Shares Worth $664,978, According to a Recent SEC Filing
Elizabeth A Grammer, Chief Legal and Administrative Officer, on March 20, 2024, sold 86,000 shares in Ardelyx (ARDX) for $664,978. Following the Form 4 filing with the SEC, Grammer has control over a
Institutional Investors May Overlook Ardelyx, Inc.'s (NASDAQ:ARDX) Recent US$195m Market Cap Drop as Long-term Gains Remain Positive
When Will Ardelyx, Inc. (NASDAQ:ARDX) Turn A Profit?
We feel now is a pretty good time to analyse Ardelyx, Inc.'s (NASDAQ:ARDX) business as it appears the company may be on the cusp of a considerable accomplishment. Ardelyx, Inc., a biopharmaceutical
No Data